Drugs / hNeo-T
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06224049 | Dec 2023 → Jun 2025 | T-cell non-Hodgkin lymphoma | BGI, China | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | hNeo-T | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06224049 ↗ |
| Modality | Cell therapy | “Targeted Haploidentical Neoantigen T Cell Injection (hNeo-T)” NCT06224049 ↗ |